Public health researchers discuss the importance of making economic evaluations of vaccines AMR-sensitive, outline how this can be done, and offer a roadmap for future research.
Sevilla, J.P., Bloom, D.E., Cadarette, D., Jit, M., Lipsitch, M. (2018). Toward economic evaluation of the value of vaccines and other health technologies in addressing AMR. PNAS, 115(51), 12911-12919.
Researchers recommend establishing a new multidisciplinary Global Technical Council on Infectious Disease Threats to better coordinate international management of volatile infectious disease risks and their consequences.
New research looking into the extra dividends of vaccination will formally quantify the broad benefits of measles vaccination on childhood health,and the long-term labor-market gains.
Promising immunizations for diseases that affect mostly people in low- and middle-income countries need help getting to market, urge David C. Kaslow and colleagues.
A new special issue of PNAS focuses on the role of vaccination in fighting antimicrobial resistance.
Public health researchers discuss the importance of making economic evaluations of vaccines AMR-sensitive, outline how this can be done, and offer a roadmap for future research. read more here
Following a call for concept notes last year, the VoVRN Secretariat, members of the Steering Committee, and external expert reviewers identified promising studies to recommend for funding. Learn more about these projects here
This position manages the research projects in the portfolio of Professor David E. Bloom, including the Value of Vaccination Research Network (VoVRN) project, a multi-year effort to fund and encourage new research on the social and economic benefits of vaccination. Learn more about job opening here
A new article explores issues of infectious diseases, threats of disruption caused by outbreaks and epidemics, and potential risk management steps including new and improved vaccines. Read more here
In the October 2017 Newsletter Issue, Dr. Brenzel thanks and welcomes the members of the Immunization Economics Community of Practice. Read her welcome letter here.